<?xml version="1.0" encoding="UTF-8"?>
<ref id="B61-pharmaceuticals-12-00147">
 <label>61.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Leneva</surname>
    <given-names>I.A.</given-names>
   </name>
   <name>
    <surname>Falynskova</surname>
    <given-names>I.N.</given-names>
   </name>
   <name>
    <surname>Makhmudova</surname>
    <given-names>N.R.</given-names>
   </name>
   <name>
    <surname>Poromov</surname>
    <given-names>A.A.</given-names>
   </name>
   <name>
    <surname>Yatsyshina</surname>
    <given-names>S.B.</given-names>
   </name>
   <name>
    <surname>Maleev</surname>
    <given-names>V.V.</given-names>
   </name>
  </person-group>
  <article-title>Umifenovir susceptibility monitoring and characterization of influenza viruses isolated during ARBITR clinical study</article-title>
  <source>J. Med. Virol.</source>
  <year>2019</year>
  <volume>91</volume>
  <fpage>588</fpage>
  <lpage>597</lpage>
  <pub-id pub-id-type="doi">10.1002/jmv.25358</pub-id>
  <?supplied-pmid 30431664?>
  <pub-id pub-id-type="pmid">30431664</pub-id>
 </element-citation>
</ref>
